Impact of Muscle Training Device on Non-Severe OSA
1 other identifier
interventional
76
1 country
1
Brief Summary
The goal of this clinical trial is to test for the efficacy of the newly invented device #DidgeriTU with non-severe obstructive sleep apnea. The main question it aims to answer is:
- Can DidgeriTU reduce apnea events in patients with non-severe obstructive sleep apnea? Researchers will compare DidgeriTU with a sham device to see how the apnea event has changed. Participants will:
- Use DidgeriTU or sham device for 3 month
- Do an online questionnaire once a month during the study
- Home sleep test, lung function test, and tongue strength test at the start and end of the study
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 19, 2025
CompletedFirst Posted
Study publicly available on registry
April 4, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2026
CompletedJanuary 21, 2026
January 1, 2026
11 months
March 19, 2025
January 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of apnea event after DidgeriTU usage compared with sham device
Participants with a known history of non-severe obstructive sleep apnea will repeat the home sleep apnea test. The study will include patients with non-severe OSA(Apnea-hypopnea index 5-29/hr) from HSAT. After the usage of DidgeriTU or sham device for 3 months, the participant will repeat HSAT to explore the change of AHI after DidgeriTU use compared with sham device.
3 months
Secondary Outcomes (7)
Change of OSA severity after the usage of DidgeriTU comparing with sham device
3 months
Change in Epworth sleepiness scale after the usage of DidgeriTU comparing with sham device
3 months
Change of maximum inspiratory pressure; MIP after DidgeriTU usage comparing with sham device
3 months
Change of maximum expiratory mouth pressure; MEP after DidgeriTU usage comparing with sham device
3 months
change in Pittsburg Sleep Quality Index; PSQI after DidgeriTU usage comparing with sham device
3 months
- +2 more secondary outcomes
Study Arms (2)
DidgeriTU
ACTIVE COMPARATORpatients with non severe OSA using DidgeriTU device
sham device
SHAM COMPARATORPatients with non severe OSA receive a device that look alike didgeriTU but without resistance plate
Interventions
the study device that immitate the principle of didgeridoo for expiratory muscle exercise
Eligibility Criteria
You may qualify if:
- Patients diagnosed with mild to moderate obstructive sleep apnea.
- Age 18 years or older.
- Patients voluntarily consent to provide information for research purposes.
You may not qualify if:
- Patients with an average apnea-hypopnea index (AHI) of \<4 or \>29 events per hour after repeated diagnosis using a home sleep apnea test.
- Patients who refused to cease using CPAP during the study process
- Patients with a history of chronic lung disease.
- Elderly patients with neurological conditions that impair cognitive function, such as dementia, stroke, or psychiatric disorders.
- Patients taking medications that may affect muscle function within 3 months before the start of the study.
- Patients with hypothyroidism or other conditions that may affect muscle function.
- Patients who consume alcohol at a moderate level or higher
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Thammasat University Hospital
Pathum Thani, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Naphitchaya Wiriya, MD.
Study Record Dates
First Submitted
March 19, 2025
First Posted
April 4, 2025
Study Start
May 1, 2025
Primary Completion
March 15, 2026
Study Completion
March 15, 2026
Last Updated
January 21, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share